Long-term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib

Jorge E. Cortes, Hanna J. Khoury, Hagop M. Kantarjian, Jeff H. Lipton, Dong Wook Kim, Philippe Schafhausen, Ewa Matczak, Eric Leip, Kay Noonan, Tim H. Brümmendorf, Carlo Gambacorti-Passerini

Research output: Contribution to journal › Article › peer-review